Cabaletta Bio Inc (CABA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -94,533 | -43,515 | -167,856 | -125,937 | -81,071 |
| Depreciation Amortization | 517 | 50 | 12,320 | 1,059 | 1,227 |
| Accounts payable and accrued liabilities | -1,177 | -269 | 1,550 | 3,256 | 2,186 |
| Other Working Capital | -9,902 | -9,371 | -379 | 1,233 | 1,018 |
| Other Operating Activity | 21,020 | 10,544 | 23,285 | 24,652 | 15,412 |
| Operating Cash Flow | $-84,075 | $-42,561 | $-131,080 | $-95,737 | $-61,228 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -1,229 | -1,024 | -946 |
| Purchase Of Investment | 50,960 | 50,960 | -49,037 | -99,037 | -49,035 |
| Investing Cash Flow | $50,960 | $50,960 | $-50,266 | $-100,061 | $-49,981 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -7,091 | -4,271 | -6,261 | -4,349 | -3,554 |
| Common Stock Issued | 182,345 | 29,538 | 106,608 | 96,364 | 96,375 |
| Financing Cash Flow | $175,254 | $25,267 | $100,347 | $92,015 | $92,821 |
| Exchange Rate Effect | -20 | -13 | 19 | 27 | 38 |
| Beginning Cash Position | 82,982 | 82,982 | 163,962 | 163,962 | 163,962 |
| End Cash Position | 225,101 | 116,635 | 82,982 | 60,206 | 145,612 |
| Net Cash Flow | $142,119 | $33,653 | $-80,980 | $-103,756 | $-18,350 |
| Free Cash Flow | |||||
| Operating Cash Flow | -84,075 | -42,561 | -131,080 | -95,737 | -61,228 |
| Capital Expenditure | N/A | N/A | -1,229 | -1,024 | -946 |
| Free Cash Flow | -84,075 | -42,561 | -132,309 | -96,761 | -62,174 |